TrialWorld journal of urology2026

Olaparib combined with abiraterone in HRR-mutated metastatic hormone-sensitive prostate cancer: a single-arm phase II trial.

Xuyu Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.